Методы лабораторной диагностики возбудителей сепсиса

1. Martin G. S., Mannino D. M., Eaton S., Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-1554.

2. Esteban A., Frutos-Vivar F., Ferguson N. D. et al. Sepsis incidence and outcome: contrasting the intensive care unit with the hospital ward. Crit Care Med 2007; 35: 1284-1289.

3. Sundararajan V., Macisaac C. M., Presnieill J. J. et al. Epidemiology of sepsis in Victoria, Australia. Ibid 2005; 33: 71-80.

4. Vincent J. L., Sakr Y., Sprung C. L. et al. Sepsis in European intensive care units: results of the SOAP study. Ibid 2006; 34: 344-353.

5. Alberti C., Brun-Bisson C., Burchardi H. et al. Epidemiology of sepsis and infection in ICU patients from an international multicenter cohort study. Intensive Care Med 2002; 28: 108-121.

6. Angus D. C., Linde-Zwirble W. T., Lidicker J. et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303-1310.

7. Jongwutiwes U., Suitharak K., Tiengrim S., Thamlikitkul V. Serum procalcitonin in diagnosis of bacteriemia. J Med Assoc Thai 2009; 92: Suppl 2: S79-87.

8. Venkatesh B., Kennedy P., Kruger P. S. et al. Changes in serum procalcitonin and C-reactive protein following antimicrobial therapy as a guide to antibiotic duration in the critically ill: a prospective evalution. Anaesth Intensive Care 2009; 37: 1: 20-26.

9. Charles P. E., Ladoire S., Aho S. et al. Serum procalcitonin elevation in critically ill patients at the onset of bacteriemia caused by either Gram negative or Gram positive bacteria. BMC Infect Dis 2008; 8: 38.

10. Venet C., Zeni F., Viallon A. et al. Endotoxaemia in patients with severe sepsis or septic shock. Intensive Care Med 2000; 5: 538-544.

11. Cohen J. The detection and interpretation of endotoxaemia. Intensive Care Med 2000; 26: Suppl 1: S51-56.

12. Sendid B., Tabouret M., Poirot J. et al. New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis. J Clin Microbiol 1999; 37: 5: 1510-1517.

13. Denning D. Invasive aspergillosis. Clin Infect Dis 1998; 26: 781-805.

14. Munoz P., Burillo A., Bouza E. Environmental surveillance and other control measures in the prevention of nosocomial fungal infections. Clin Microbiol Infect Dis. 2001; 7 Suppl 2: 38-45.

15. Bretagne S., Marmorat-Khuong A., Kuentz M. Aspergillus galactomannan antigen testing by sandwich ELISA: practical use in neutropenic patients. J Infect. 1997; 35: 7-15.

16. Maertens J., Verhaegen J., Lagrou K. et al. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001; 97: 6: 1604-1610.

17. Wellinghausen N., Siegel D., Winter J., Gebert S. Rapid diagnosis of candidaemia by real-time PCR detection of Candida DNA in blood samples. J Med Microbiol. 2009; 58: 8: 1106-1111.

18. Lehmann L. E., Alvarez J., Hunfeld K. P. et al. Potential clinical utility of polymerase chain reaction in microbiological testing for sepsis. Crit Care Med 2009; 37: 12: 3085-3090.

19. Lodes U., Meyer F., Konig B., Lippert H. Microbiological sepsis screening in surgical ICU patients with the LightCycler Septifast test - a pilot study. Zentralbl Chir 2009; 134: 3: 249-253.

20. Dierkes C., Ehrenstein B., Siebig S. Clinical impact of a commercially available multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis. BMC Infect Dis 2009; 9: 126.

21. Kane T. D., Alexander J. W., Johannigman J. A. The detection of microbial DNA in the blood: a sensitive method for diagnosing bacteriemia and/or bacterial translocation in surgical patients. Ann Surg 1998; 227: 1-9.

22. Ziegler R., Johnscher I., Martus P. Controlled clinical laboratory comparison of two supplemented aerobic and anaerobic media used in automated blood culture systems to detect bloodstream infections. J Clin Microbiol 1998; 36: 657-661.

23. Vigano E. F., Vasconi E., Agrappi C., Clerici P. Use of simulated blood cultures for time to detection comparison between BacT/ALERT and BACTEC 9240 blood culture systems. Diagnostic Microbiology and Infectious Disease 2002; 44: 235-240.

24. Speers D. J., Olma T. R., Gilbert G. L. Evaluation of four methods for rapid identification of Staphylococcus aureus from blood cultures. J Clin Microbiol 1998; 36: 4: 1032-1034.

25. Tan G. L., Peterson E. M. CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures. J Clin Microbiol 2005; 43: 4: 1727-1731.

26. Chihara S., Hayden M. K., Minogue-Corbett E., Singh K. Shortened time to identify Staphylococcus species from blood cultures and methicillin resistance testing using CHROMAgar. Int J Microbiol 2009; 2009: 636-502.

27. Yagupsky P., Nolte F. S. Quantitative aspects of septicemia. Clin Microbiol Rev 1990; 3: 269-279.

28. Rohner P., Auckenthaler R. Review on evaluations of currently available blood culture systems. Clin.Microbiol Infect 1999; 5: 513-529.

29. Tokars J. Predictive value of blood cultures positive for coagulase-negative staphylococci: implications for patient care and health care quality assurance. Clin Infect Dis 2004; 39: 334-341.

30. Hall K. K., Lyman J. A. Updated review ofblood culture contamination. Clin Microbiol Rev 2006; 19: 788-802.

31. Madeo M., Jakson T., Williams C. Simple measures to reduce the rate of contamination of blood cultures in Accident and Emergency. Emerg.Med J 2005; 22: 810-811.

32. Orrett F. A., Changoor E. Bacteriemia in children at a regional hospital in Trinidad. Int J Infect Dis 2007; 11: 2: 145-151.

33. Falagas M. E., Bakossi A., Pappas V. D. Secular trends of blood isolates in patients from a rural area population hospitalized in a tertiary center in a small city in Greece. BMC Microbiol 2006; 6: 41.

34. Wisplinghoff H., Bischoff T., Tallent S. M. Nosocomial bloodstream infections in US hospitals: analysis of 24179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 3: 309-317.

35. Ozturk F., Gundes S., Isik C. Prospective evaluation of the risk factors, etiology and the antimicrobial susceptibilities of the isolates in nosocomial bacteriemic patients. Mikrobiyol Bul 2008; 42: 1: 17-27.

36. Hufnagel M., Burger A., Bartelt S. Secular trends in pediatric bloodstream infections over a 20-year period at a tertiary care hospital in Germany. Eur J Pediatr 2008; 167: 10: 1149-1159.

37. Hill P. C., Onyeama C. O., Ikumapayi U. N. Bacteriemia in patients admitted to an urban hospital in West Africa. BMC Infect Dis 2007; 7: 2.

38. Saghir S., Faiz M., Saleem M. Characterization and anti-microbial susceptibility of gram-negative bacteria isolated from bloodstream infections of cancer patients on chemotherapy in Pakistan. Indian J Med Microbiol 2009; 27: 4: 341-347.

39. Superti S. V., Augusti G., Zavascki A. P. Risk factors for and mortality of extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli nosocomial bloodstream infections. Rev Inst Med Trop Sao Paulo 2009; 51: 211- 216.

40. Lautenbach E., Synnestvedt M., Weiner M. G. Imipenem resistance in Pseudomonas aeruginosa: emergence, epidemiology, and impact on clinical and economic outcomes. Infect Control Hosp Epidemiol 2010; 31: 1: 47-53.

41. Rubio-Terres C., Garau J., Grau S., Martinez L. Cost of bacteriemia caused by methicillin-resistant vs. methicillin-susceptible Staphylococcus aureus in Spain. ESCMID 2008, Abstract P1730.

42. Reynolds R., Potz N., Colman M. Antimicrobial susceptibility of the pathogens of bacteriemia in the UK and Ireland in 2001-2002: the BSAC bacteriemia resistance surveillance programme. J Antimicrob Chemother 2004; 53: 6: 1018-1032.

43. Brink A., Moolman J., da Silva M. C., Botha M. Antimicrobial susceptibility profile of selected bacteriemic pathogens from private institutions in South Africa. S Afr Med J 2007; 97: 4: 273-279.

44. Koksal F., Ak K., Kucukbasmaci O., Samasti M. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital. Chemotherapy 2009; 55: 4: 293-297.